Cleared Traditional

K182624 - MIM - MRT Dosimetry

K182624 is the FDA 510(k) clearance for MIM - MRT Dosimetry by Mim Software, Inc.. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 85-day FDA review.

K182624 · Mim Software, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2018
Decision
85d
Days
Class 2
Risk

K182624 is an FDA 510(k) clearance for the MIM - MRT Dosimetry. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Mim Software, Inc. (Beachwood, US). The FDA issued a Cleared decision on December 18, 2018 after a review of 85 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Mim Software, Inc. devices

Submission Details

510(k) Number K182624 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 24, 2018
Decision Date December 18, 2018
Days to Decision 85 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
22d faster than avg
Panel avg: 107d · This submission: 85d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1055
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K182624.
4D View
K182750 · GE Medical Systems Ultrasound and Primary Care Diagnostics · Dec 2018
vascuCAP
K183012 · Elucid Bioimaging, Inc. · Dec 2018
3DIEMME RealGUIDE
K173041 · 3Diemme , Ltd. · Dec 2018
Centricity Universal Viewer
K182419 · Ge Healthcare · Dec 2018
Vitrea Software Package, VSTP-001A
K182601 · Canon Medical Systems Corporation · Dec 2018
HipCheck
K182359 · Stryker Corp. · Dec 2018